For SNAI1, amplification ranked first among all alteration types in colorectal adenocarcinoma (6.73%), esophageal adenocarcinoma (4.4%), and invasive breast carcinoma (3.41%). This evidence concerns the gene SNAI1 and invasive breast carcinoma.